Delivery Order SPE2DB20D3103-SPE2DB22FP0F6
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,122.32, is for the delivery of Multihance 529 mg/ml vial (10 ml). The order has a completion date of September 13, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,216.36, is for the medical product MULTIHANCE 529MG/ML 5S. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Multihance 529mg/ml. The delivery order, valued at $5,323.05, has a firm fixed price and an ultimate completion date of March 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,659.26, is a Delivery Order that covers the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,989.50 firm fixed-price Delivery Order, awarded on November 8, 2022, is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product. The contract has an ultimate completion date of November 9, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML medical products. The contract, valued at $6,100.40, is a firm fixed-price delivery order with a completion date of September 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564411945 - MULTIHANCE 529 MG/ML VIAL 20ML. This $3,371.14 Firm Fixed Price contract has an ultimate completion date of April 29, 2024 and was awarded on April 26, 2024. Amerisourcebergen, a subsidiary of Cencora, Inc., has extensive experience providing a wide range of prescription drugs, medical supplies, and critical care products...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,526.36 Firm Fixed Price Delivery Order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of August 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
- This is a federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,208.48, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts, including a significant Indefinite Delivery Contract...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,177.28 firm-fixed-price contract has a completion date of January 21, 2025 and covers the provision of a range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP0F6Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The $2,609.26 firm fixed-price contract has a completion date of June 28, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/27/22 |